Bioproduction Market Size and Forecasts (2020-2030)

Bioproduction Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry

$3,633$6,433

Description

According to our latest study on “Bioproduction Market Forecast to 2030 – Global Analysis –Surgery Type, Type, and End User,” the Bioproduction market value is expected to reach US$ 63.393 billion by 2030 from US$ 22.337 billion in 2022. The report highlights trends occurring in the market and factors driving and hindering the growth of the bioproduction market.
Automation can deliver many benefits for cell therapy developers, including reduced risk of contamination, improved consistency, and reduced cost of production. Many companies have offered devices to enable automation, such as the Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi, which are designed to enable the automation of most successive unit operations for a CAR-T process within a single system. A rising number of cell therapies have shifted the production of cell therapy goods from a small volume to a large volume worldwide. In addition, the evolution of cell therapy, from an academic and clinical setting to mass production and commercialization is increasing the demand for automation in manufacturing. Increasing research activities in cell therapies have led to a rise in demand for advanced manufacturing solutions. In view of this, many players are offering products to meet the digital needs of academic researchers and large biotechnology companies. For instance, in May 2019, GE Healthcare launched the Chronicle web application to support the complete cell therapy workflow. Chronicle automation software is a good manufacturing practice (GMP)- a compliant digital solution designed to optimize complex cell therapy process development and manufacturing.
Companies are also entering into strategic and technological developments for automation in cell therapy. For instance, in July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop and manufacture processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the fitness of T-cells and support the development of an integrated current good manufacturing practice (cGMP) compliant platform (system and software) along with reagents, consumables, and instruments. In March 2019, Lonza partnered with Israel’s Sheba Medical Center to provide automated and closed CAR-T manufacturing using its point-of-care Cocoon cell therapy manufacturing platform. Thus, the increasing adoption of automation among cell therapy manufacturers is anticipated to drive the market.
The bioproduction market, by product, is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest market share in 2022. The cell and gene therapies segment is estimated to register the highest CAGR in the market from 2022 to 2030. Cell therapy and gene therapy are the overlapping fields in biomedical treatment and research. Both therapies aim to prevent, treat, or potentially cure diseases.
Moreover, both therapies can improve the underlying cause of genetic and acquired diseases. Cell therapy intends to treat diseases by restoring or modifying several sets of cells outside the body before being injected into the patient or by using cells to carry a therapy across the body. Gene therapy aims to treat diseases by restoring or introducing new genes into cells—either outside of the body (ex vivo) or inside the body (in vivo). The gene therapies work by adjusting genes in specific types of cells and incorporating them into the body.
The bioproduction market, by equipment, is segmented into consumables and accessories, downstream equipment, bioreactors, and upstream equipment. The consumables and accessories segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR of 14.7% in the market during 2022–2030. Bioproduction involves utilizing various consumables and accessories, such as cells, reagents, enzymes, and growth mediums. It also requires disposable glassware and plastic ware such as petri dishes, test tubes, pipettes, automated pipette tips, and beakers. All the products mentioned above are known as consumables. Consumables are used at every step of the cell therapy manufacturing process. They are also required at the time of the quality control (QC) process to ensure appropriate quality testing. Continuous research and developments in the biopharmaceutical industry are likely to demand more consumables and accessories in the coming years. These are also demanded in greater quantities as, most of the time, consumables are used for trial-and-error processes.
The bioproduction market, by end-users, is segmented into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest share of the market in 2022. However, contract manufacturing organizations are anticipated to register the highest CAGR of 14.7% in the market from 2022 to 2030. A contract research organization (CRO) presents support services to biotechnology, pharmaceutical, and medical device companies throughout product development. CROs specialize in research and bring value to pharmaceutical and biotechnology companies by saving them infrastructure and R&D facility costs, as well as reducing the time involved in conducting clinical trials. These organizations require various services for detecting specific diagnosing of diseases, mapping genes, and identifying novel oncogenes or genetic aberrations contributing to various cancers.
United States Food and Drug Administration (USFDA), Institute for Clinical and Economic Review (ICER), and Centers for Disease Control and Prevention (CDC) are a few key primary and secondary sources mentioned while preparing the report on the bioproduction market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

Biologics and Biosimilars Segment by Product to Account for Larger Share in Bioproduction Market during 2022–2030

According to our latest study on “Bioproduction Market Forecast to 2030 – Global Analysis – by Product, Application, Equipment, and End User,” the bioproduction market value is expected to reach US$ 63.393 billion in 2030 from US$ 22.337 billion in 2022. The report emphasizes the key factors driving the market and prominent players with their developments. The rising adoption of regenerative medicines and the increasing prevalence of chronic diseases are the key driving factors behind the market development. However, the high cost of cell therapy and biosimilar manufacturing is hampering the market growth.

Biosimilars are safe and efficient treatments for a wide range of disorders, including cancer, irritable bowel syndrome, psoriasis, Crohn’s disease, and colitis, as well as arthritis and kidney problems. Biosimilars might result in cheaper costs as compared to biologics. Medications classified as biologics are those that are derived from living things, such as bacteria and yeast, microorganisms, and animal cells. This distinguishes biologics from traditional drugs, which are typically derived from chemicals. A wide range of illnesses with unmet medical needs, such as cancer, diabetes, cystic fibrosis, chronic renal disease, and autoimmune disorders, can be prevented, treated, or cured with biologics. Biosimilars are similar to the original biologic in terms of safety and efficacy. The FDA carefully and thoroughly reviews both before approving them. Manufacturers must demonstrate that patients using biosimilars do not have any new or worsening side effects in comparison to those using the original biologics in order for the FDA to approve the product.

The North America bioproduction market is sub-segmented into the US, Canada, and Mexico. In Mexico, the demand for cell therapy is quite noteworthy owing to growing medical tourism for stem cell therapy. The bioproduction market in North America accounted for the largest market share in 2022 due to the increasing incidence of diabetes and infertility, as well as rising product developments in biosimilars. Growing incidences of genetic and cellular disorders are leading to increasing demand for cell therapies. A 2020 PhRMA report on the cell and gene therapy pipeline revealed that there are 400 cell and gene therapies in development to target a variety of diseases and conditions in the US, from cancer to genetic disorders to neurological conditions. As of February 2020, nine cell or gene therapy products were approved in the US to treat cancer, eye diseases, and rare hereditary diseases. Also, an increasing number of start-ups are innovating cell therapies in the country.
In the US, biosimilars are used to treat patients with cancers, kidney diseases, diabetes, and other autoimmune diseases such as Crohn’s disease and rheumatoid arthritis. According to Cardinal Health, a total of 33 biosimilars have been approved by the FDA in the US, and 21 are commercially available. Of the 21 biosimilars in the market, 17 are used for treatments associated with cancers, three are used to treat autoimmune conditions, and one is used to treat diabetes. Biosimilars are anticipated to be priced 15% to 30% lower than the biologics. In 2020 alone, biosimilars saved US$ 7.9 billion, with savings estimated to grow substantially in the next few years as more biosimilars enter the market. According to Cardinal Health, biosimilars are expected to reduce US drug expenditure by US$ 133 billion by 2025. In addition, growing support from the government is enhancing the growth of cell therapies, which is influencing the growth of the bioproduction market.

Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories Inc are the prominent bioproduction market players.

Companies operating in the bioproduction market adopt various organic and inorganic strategies. Growth strategies mainly include product launches and product approvals, mergers & acquisitions, collaborations, and partnerships are among the growth strategies witnessed in the bioproduction market.
A few of the significant developments by key market players are listed below.

• Various initiatives taken by leading players operating in the global bioproduction market are listed below:
• In March 2023, Lonza declared that its intended cGMP clinical and commercial drug product production line in Visp (CH) had been completed. Customers with a range of production demands for drug products, for both clinical and commercial supply, will be served by the new line. Modern liquid and lyophilized vial filling isolator line for multiple modalities that satisfies the GMP Annex 1 requirement for manufacturing sterile products is part of this 1,200 square meter cGMP facility. The line is already completely operating and has a cGMP license; in April 2023, the first client batches are scheduled to be filled.
• In October 2023, Lonza declared the continuation of a long-term partnership with a significant international biopharmaceutical partner. The extension of the agreement will add two new bioconjugation suites for the commercial supply of ADCs at Lonza’s Ibex® Dedicate Biopark in Visp (CH), therefore quadrupling the current dedicated bioconjugation capacity. The addition will take up 1,500 square meters of production area and be connected to vital infrastructure that allows for the processing of bioconjugates in a highly automated, high throughput setting and the containment of extremely powerful drug linkers.
• In October 2023, Lonza announced the expansion of a partnership for the commercial-scale filling of ADCs with a significant biopharmaceutical partner. At its Stein (CH) facility, Lonza is required under the agreement to build a specialized aseptic cGMP filling line on a commercial scale. The aseptic filling of highly potent ADCs and containment lyophilization will be made possible by the new dedicated filling line. The extra-filling capabilities bolster Lonza’s ability and adaptability further to support the commercial and clinical supply of bioconjugates.

 

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the bioproduction market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global bioproduction market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Bioproduction Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Bioproduction Market Landscape
4.1 Overview
4.1.1 Global PEST Analysis
5. Bioproduction Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Rising Adoption of Regenerative Medicines
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
5.3 Market Opportunities
5.3.1 Patent Expiry of Blockbuster Biologics
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis
6. Bioproduction Market – Global Market Analysis
6.1 Bioproduction Market Revenue (US$ Mn), 2022 – 2030
7. Global Bioproduction Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Biologics and Biosimilars
7.3.1 Overview
7.3.2 Biologics and Biosimilars: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Vaccines
7.4.1 Overview
7.4.2 Vaccines: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Cell and Gene Therapies
7.5.1 Overview
7.5.2 Cell and Gene Therapies: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Nucleic Acid Therapeutics
7.6.1 Overview
7.6.2 Nucleic Acid Therapeutics: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Bioproduction Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cardiovascular Diseases
8.4.1 Overview
8.4.2 Cardiovascular Diseases: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Rheumatoid Arthritis
8.5.1 Overview
8.5.2 Rheumatoid Arthritis: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Hematological Disorders
8.6.1 Overview
8.6.2 Hematological Disorders: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Diabetes
8.7.1 Overview
8.7.2 Diabetes: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Bioproduction Market – Revenue and Forecast to 2030 – by Equipment
9.1 Overview
9.2 Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
9.3 Consumables and Accessories
9.3.1 Overview
9.3.2 Consumables and Accessories: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Downstream Equipment
9.4.1 Overview
9.4.2 Downstream Equipment: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Bioreactors
9.5.1 Overview
9.5.2 Bioreactors: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
9.5.2.1 Global: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
9.6 Upstream Equipment
9.6.1 Overview
9.6.2 Upstream Equipment: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Bioproduction Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Contract Manufacturing Organizations
10.4.1 Overview
10.4.2 Contract Manufacturing Organizations: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11. Bioproduction Market – Revenue and Forecast to 2030 – Geographic Analysis
11.1 North America: Bioproduction Market
11.1.1 Overview
11.1.2 North America: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.1.4 North America: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.1.5 North America: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.1.5.1 North America: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.1.6 North America: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.1.6.1 US: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.1 Overview
11.1.6.1.2 US: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.3 US: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.1.6.1.4 US: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.1.6.1.5 US: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.1.6.1.5.1 US: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.1.6.1.6 US: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.1.6.2 Canada: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.1 Overview
11.1.6.2.2 Canada: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.3 Canada: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.1.6.2.4 Canada: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.1.6.2.5 Canada: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.1.6.2.5.1 Canada: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.1.6.2.6 Canada: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.1.6.3 Mexico: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.1 Overview
11.1.6.3.2 Mexico: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.3 Mexico: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.1.6.3.4 Mexico: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.1.6.3.5 Mexico: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.1.6.3.5.1 Mexico: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.1.6.3.6 Mexico: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.2 Europe: Bioproduction Market
11.2.1 Overview
11.2.2 Europe: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.2.4 Europe: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.2.5 Europe: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.2.5.1 Europe: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.2.6 Europe: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.2.7 Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
11.2.7.1 Germany: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.3 Germany: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.2.7.1.4 Germany: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.2.7.1.5 Germany: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.2.7.1.5.1 Germany: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.2.7.1.6 Germany: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.2.7.2 UK: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 UK: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.3 UK: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.2.7.2.4 UK: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.2.7.2.5 UK: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.2.7.2.5.1 UK: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.2.7.2.6 UK: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.2.7.3 France: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 France: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.3 France: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.2.7.3.4 France: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.2.7.3.5 France: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.2.7.3.5.1 France: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.2.7.3.6 France: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.2.7.4 Italy: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.3 Italy: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.2.7.4.4 Italy: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.2.7.4.5 Italy: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.2.7.4.5.1 Italy: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.2.7.4.6 Italy: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.2.7.5 Spain: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.3 Spain: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.2.7.5.4 Spain: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.2.7.5.5 Spain: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.2.7.5.5.1 Spain: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.2.7.5.6 Spain: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.2.7.6 Rest of Europe: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.3 Rest of Europe: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.2.7.6.4 Rest of Europe: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.2.7.6.5 Rest of Europe: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.2.7.6.5.1 Rest of Europe: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.2.7.6.6 Rest of Europe: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific: Bioproduction Market
11.3.1 Overview
11.3.2 Asia Pacific: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.3.5.1 Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.3.7 Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
11.3.7.1 China: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 China: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.3 China: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.3.7.1.4 China: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.3.7.1.5 China: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.3.7.1.5.1 China: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.3.7.1.6 China: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.3.7.2
11.3.7.3 India: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.3 India: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.3.7.3.4 India: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.3.7.3.5 India: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.3.7.3.5.1 India: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.3.7.3.6 India: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.3.7.4 Japan: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 Japan: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.3 Japan: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.3.7.4.4 Japan: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.3.7.4.5 Japan: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.3.7.4.5.1 Japan: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.3.7.4.6 Japan: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.3.7.5 Australia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 Australia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.3 Australia: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.3.7.5.4 Australia: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.3.7.5.5 Australia: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.3.7.5.5.1 Australia: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.3.7.5.6 Australia: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.3.7.6 South Korea: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 South Korea: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.3 South Korea: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.3.7.6.4 South Korea: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.3.7.6.5 South Korea: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.3.7.6.5.1 South Korea: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.3.7.6.6 South Korea: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.3.7.7 Rest of Asia Pacific: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.7.1 Overview
11.3.7.7.2 Rest of Asia Pacific: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.7.3 Rest of Asia Pacific: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.3.7.7.4 Rest of Asia Pacific: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.3.7.7.5 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.3.7.7.5.1 Rest of Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.3.7.7.6 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.4 Middle East & Africa Bioproduction Market
11.4.1 Overview
11.4.2 Middle East & Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.4.5.1 Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment by Application, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.4.6.1 Saudi Arabia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.6.1.1 Overview
11.4.6.1.2 Saudi Arabia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.6.1.3 Saudi Arabia: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.4.6.1.4 Saudi Arabia: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.4.6.1.5 Saudi Arabia: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.4.6.1.5.1 Saudi Arabia: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.4.6.1.6 Saudi Arabia: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.4.6.2 South Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.6.2.1 Overview
11.4.6.2.2 South Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.6.2.3 South Africa: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.4.6.2.4 South Africa: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.4.6.2.5 South Africa: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.4.6.2.5.1 South Africa: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.4.6.2.6 South Africa: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.4.6.3 UAE: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.6.3.1 Overview
11.4.6.3.2 UAE: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.6.3.3 UAE: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.4.6.3.4 UAE: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.4.6.3.5 UAE: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.4.6.3.5.1 UAE: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.4.6.3.6 UAE: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.4.6.4 Rest of Middle East & Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.6.4.1 Overview
11.4.6.4.2 Rest of Middle East & Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.4.6.4.3 Rest of Middle East & Africa: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.4.6.4.4 Rest of Middle East & Africa: Bioproduction Market, by Application, 2020–2030 (US$ Million)
11.4.6.4.5 Rest of Middle East & Africa: Bioproduction Market, by Equipment, 2020–2030 (US$ Million)
11.4.6.4.5.1 Rest of Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020–2030 (US$ Million)
11.4.6.4.6 Rest of Middle East & Africa: Bioproduction Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America: Bioproduction Market
11.5.1 Overview
11.5.2 South & Central America: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.5.4 South & Central America: Bioproduction Market, By Application, 2020–2030 (US$ Million)
11.5.5 South & Central America: Bioproduction Market, By Equipment, 2020–2030 (US$ Million)
11.5.5.1 South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020–2030 (US$ Million)
11.5.6 South & Central America: Bioproduction Market, By End User, 2020–2030 (US$ Million)
11.5.7 South & Central America: Bioproduction Market Share by Country – 2022 & 2030, (%)
11.5.7.1 Brazil: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.1 Overview
11.5.7.2 Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
11.5.7.2.1 Brazil: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.5.7.2.2 Brazil: Bioproduction Market, By Application, 2020–2030 (US$ Million)
11.5.7.2.3 Brazil: Bioproduction Market, By Equipment, 2020–2030 (US$ Million)
11.5.7.2.3.1 Brazil: Bioproduction Market, for Bioreactors by Equipment, 2020–2030 (US$ Million)
11.5.7.2.4 Brazil: Bioproduction Market, By End User, 2020–2030 (US$ Million)
11.5.7.3 Argentina: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.1 Overview
11.5.7.4 Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
11.5.7.4.1 Argentina: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.5.7.4.2 Argentina: Bioproduction Market, By Application, 2020–2030 (US$ Million)
11.5.7.4.3 Argentina: Bioproduction Market, By Equipment, 2020–2030 (US$ Million)
11.5.7.4.3.1 Argentina: Bioproduction Market, for Bioreactors by Equipment, 2020–2030 (US$ Million)
11.5.7.4.4 Argentina: Bioproduction Market, By End User, 2020–2030 (US$ Million)
11.5.7.5 Rest of South & Central America: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.5.1 Overview
11.5.7.6 Rest of South & Central America: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.6.1 Rest of South & Central America: Bioproduction Market, by Product, 2020–2030 (US$ Million)
11.5.7.6.2 Rest of South & Central America: Bioproduction Market, By Application, 2020–2030 (US$ Million)
11.5.7.6.3 Rest of South & Central America: Bioproduction Market, By Equipment, 2020–2030 (US$ Million)
11.5.7.6.3.1 Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020–2030 (US$ Million)
11.5.7.6.4 Rest of South & Central America: Bioproduction Market, By End User, 2020–2030 (US$ Million)
12. Bioproduction Market–Industry Landscape
12.1 Overview
13. Company Profiles
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Bioproduction Market Segmentation
Table 2. Global Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 8. US Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. US Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 10. US Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 11. US Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 12. US Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Mexico Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 19. Mexico Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 23. Europe Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 24. Europe Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. Europe Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 28. Germany Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 29. Germany Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 30. Germany Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 31. Germany Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 32. Germany Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 33. UK Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 34. UK Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 35. UK Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 36. UK Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 37. UK Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 38. France Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 39. France Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 40. France Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 41. France Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 42. France Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 43. Italy Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 44. Italy Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 45. Italy Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 46. Italy Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 47. Italy Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 48. Spain Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 49. Spain Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 50. Spain Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 51. Spain Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 52. Spain Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 53. Rest of Europe Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 54. Rest of Europe Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 55. Rest of Europe Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 56. Rest of Europe Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 57. Rest of Europe Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 58. Asia Pacific Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 59. Asia Pacific Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 60. Asia Pacific Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 61. Asia Pacific Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 62. Asia Pacific Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 63. China Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 64. China Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 65. China Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 66. China Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 67. China Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 68. India Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 69. India Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 70. India Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 71. India Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 72. India Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 73. Japan Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 74. Japan Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 75. Japan Bioproduction Market, by Equipment– Revenue and Forecast to 2030 (US$ Million)
Table 76. Japan Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 77. Japan Bioproduction Market, by End User– Revenue and Forecast to 2030 (US$ Million)
Table 78. Australia Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 79. Australia Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 80. Australia Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 81. Australia Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 82. Australia Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 83. South Korea Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 84. South Korea Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 85. South Korea Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 86. South Korea Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 87. South Korea Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 88. Rest of Asia Pacific Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 89. Rest of Asia Pacific Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 90. Rest of Asia Pacific Bioproduction Market, by Equipment– Revenue and Forecast to 2030 (US$ Million)
Table 91. Rest of Asia Pacific Bioproduction Market, For Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 92. Rest of Asia Pacific Bioproduction Market, by Equipment– Revenue and Forecast to 2030 (US$ Million)
Table 93. Middle East & Africa Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 94. Middle East & Africa Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 95. Middle East & Africa Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 96. Middle East & Africa Bioproduction Market, For Bioreactors by Equipment by Application – Revenue and Forecast to 2030 (US$ Million)
Table 97. Middle East & Africa Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 98. Saudi Arabia Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 99. Saudi Arabia Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 100. Saudi Arabia Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 101. Saudi Arabia Bioproduction Market, For Bioreactors by Equipment by Application – Revenue and Forecast to 2030 (US$ Million)
Table 102. Saudi Arabia Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 103. South Africa Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 104. South Africa Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 105. South Africa Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 106. South Africa Bioproduction Market, For Bioreactors by Equipment– Revenue and Forecast to 2030 (US$ Million)
Table 107. South Africa Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 108. UAE Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 109. UAE Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 110. UAE Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 111. UAE Bioproduction Market, For Bioreactors by Equipment– Revenue and Forecast to 2030 (US$ Million)
Table 112. UAE Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 113. Rest of Middle East & Africa Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 114. Rest of Middle East & Africa Bioproduction Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 115. Rest of Middle East & Africa Bioproduction Market, by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 116. Rest of Middle East & Africa Bioproduction Market, For Bioreactors by Equipment– Revenue and Forecast to 2030 (US$ Million)
Table 117. Rest of Middle East & Africa Bioproduction Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 118. South & Central America: Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 119. South & Central America: Bioproduction Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 120. South & Central America: Bioproduction Market, By Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 121. South & Central America: Bioproduction Market, for Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 122. South & Central America: Bioproduction Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 123. Brazil: Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 124. Brazil: Bioproduction Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 125. Brazil: Bioproduction Market, By Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 126. Brazil: Bioproduction Market, for Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 127. Brazil: Bioproduction Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 128. Argentina: Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 129. Argentina: Bioproduction Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 130. Argentina: Bioproduction Market, By Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 131. Argentina: Bioproduction Market, for Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 132. Argentina: Bioproduction Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 133. Rest of South & Central America: Bioproduction Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of South & Central America: Bioproduction Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of South & Central America: Bioproduction Market, By Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of South & Central America: Bioproduction Market, By End User – Revenue and Forecast to 2030 (US$ Million)
Table 138. Glossary of Terms, Bioproduction Market

LIST OF FIGURES

Figure 1. Bioproduction Market Segmentation, By Geography
Figure 2. Global – PEST Analysis
Figure 3. Bioproduction Market: Key Industry Dynamics
Figure 4. Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 5. Bioproduction Market Revenue (US$ Mn), 2020 – 2030
Figure 6. Global Bioproduction Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Biologics and Biosimilars: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vaccines: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Cell and Gene Therapies: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Nucleic Acid Therapeutics: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 14. Cancer: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Cardiovascular Diseases: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Rheumatoid Arthritis: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hematological Disorders: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Diabetes: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 21. Consumables and Accessories: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Downstream Equipment: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Bioreactors: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Upstream Equipment: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 26. Biopharmaceutical Companies: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Contract Manufacturing Organizations: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. North America Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. North America: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 32. US: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Canada: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Mexico: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Europe: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 36. Europe Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Europe: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 38. Germany: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. UK: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. France: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. Italy: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Spain: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Rest of Europe: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Asia Pacific: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 45. Asia Pacific Bioproduction Market Revenue and Forecast to 2030 (US$ Million)
Figure 46. Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 47. China: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 48. India: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 49. Japan: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. Australia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. South Korea: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. Rest of Asia Pacific: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. Middle East & Africa: Bioproduction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 54. Middle East & Africa Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 55. Middle East & Africa: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 56. Saudi Arabia: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 57. South Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 58. UAE: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 59. Rest of Middle East & Africa: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
Figure 60. South & Central America: Bioproduction Market, By Key Country – Revenue (2022) (US$ Million)
Figure 61. South & Central America: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 62. South & Central America: Bioproduction Market Share by Country – 2022 & 2030, (%)
Figure 63. Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 64. Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 65. Rest of South & Central America: Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)

The List of Companies – Bioproduction Market
o Thermo Fisher Scientific Inc           
o Merck KGaA         
o F. Hoffmann-La Roche Ltd              
o Bio-Rad Laboratories Inc                  
o Lonza Group AG  
o bbi-biotech GmbH  
o Danaher Corp      
o Sartorius AG         
o FUJIFILM Irvine Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “Bioproduction Market Size and Forecasts (2020-2030)”